Samsung Bioepis Snags Second Soliris Biosimilar In Europe
As Three Generics From Accord And Extrovis Also Receive CHMP Nods
Samsung Bioepis has seen its SB12 proposed eculizumab biosimilar rival to Soliris endorsed by the EMA’s CHMP. At the same time, three generics also received positive CHMP opinions.
